Literature DB >> 11172292

Gastric atrophy and extent of intestinal metaplasia in a cohort of Helicobacter pylori-infected patients.

J Guarner1, R Herrera-Goepfert, A Mohar, L Sanchez, D Halperin, C Ley, J Parsonnet.   

Abstract

Atrophy and intestinal metaplasia (IM) are preneoplastic gastric lesions associated with Helicobacter pylori infection. Atrophy and IM are usually found together; however, the association between increasing degrees of severity of both atrophy and IM has not been evaluated completely. Two pathologists graded atrophy and IM using the visual analog scale of the Sydney classification in gastric biopsies from 368 H pylori-infected patients. Extent of IM also included determining the number of specimens affected. We then correlated the degree of atrophy with the degree and number of specimens affected with IM by calculating relative risks (RR) and 95% confidence intervals (95% CI). The mean number of biopsies examined from each patient was 6.5. Atrophy and IM were found more frequently in the antrum (85% and 75% of biopsies, respectively). One hundred thirty-eight patients had a combination of atrophy and IM, 48 had IM only, and 89 had atrophy only. Fifty-three subjects had mild atrophy and IM (RR = 1.57; 95% CI 1.2-2.1), 69 had moderate atrophy and IM (RR = 1.86; 95% CI 1.9-2.4), and 16 had marked atrophy and IM (RR = 2.47; 95% CI 1.8-3.3). The median number of biopsy specimens with IM increased from 0 in subjects with no atrophy to 3 in subjects with severe atrophy. The degree of IM correlated with the degree of atrophy; the median degree was 0.6 in subjects with no atrophy and increased to 2.32 in those with severe atrophy. Our data suggest that higher degrees of IM in an individual specimen and increasing number of specimens with IM are associated with moderate or severe degrees of atrophy.

Entities:  

Mesh:

Year:  2001        PMID: 11172292     DOI: 10.1053/hupa.2001.20889

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Serum pepsinogens and Helicobacter pylori in relation to the risk of esophageal squamous cell carcinoma in the alpha-tocopherol, beta-carotene cancer prevention study.

Authors:  Michael B Cook; Sanford M Dawsey; Lena Diaw; Martin J Blaser; Guillermo I Perez-Perez; Christian C Abnet; Philip R Taylor; Demetrius Albanes; Jarmo Virtamo; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.

Authors:  Barik A Salih; M Fatih Abasiyanik; Huseyin Saribasak; Osman Huten; Ersan Sander
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  Trefoil Factor 2 Regulates Proliferation and Apoptosis of Pancreatic Cancer Cells and LPS-Induced Normal Pancreatic Duct Cells by β-Catenin Pathway.

Authors:  Yun Zhou; Yan Zhang; Jia Wang
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

4.  AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Authors:  Osama Altayar; Perica Davitkov; Shailja C Shah; Andrew J Gawron; Douglas R Morgan; Kevin Turner; Reem A Mustafa
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

5.  Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea.

Authors:  Young-Eun Joo; Hyun-Kyung Park; Dae-Seong Myung; Gwang-Ho Baik; Jeong-Eun Shin; Geom-Seog Seo; Gwang Ha Kim; Heung Up Kim; Hyun Young Kim; Sung-Il Cho; Nayoung Kim
Journal:  Gut Liver       Date:  2013-05-13       Impact factor: 4.519

6.  Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations.

Authors:  Perica Davitkov; Osama Altayar; Shailja C Shah; Andrew J Gawron; Reem A Mustafa; Shahnaz Sultan; Douglas R Morgan
Journal:  Gastroenterology       Date:  2019-12-06       Impact factor: 22.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.